4.4 Review

COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Cardiac Manifestations of Viral Infections, Including COVID-19

Hillary Weisleder et al.

Cardiology in Review (2023)

Article Cardiac & Cardiovascular Systems

Impact of the COVID-19 Pandemic on Patients Without COVID-19 With Acute Myocardial Infarction and Heart Failure

Daniel K. Fox et al.

Summary: Excess mortality from cardiovascular disease has been observed during the COVID-19 pandemic. This study found that the increased mortality was mainly driven by a higher death rate among patients with acute myocardial infarction, while the mortality rate for heart failure patients remained unchanged. The authors suggest that the delay or deferral of care may have contributed to worse cardiovascular outcomes during the pandemic.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Review Medicine, General & Internal

Early impact of the COVID-19 pandemic on in-person outpatient care utilisation: a rapid review

Julien Dupraz et al.

Summary: This study aimed to assess the early impact of the COVID-19 pandemic on in-person outpatient care utilization worldwide. The results showed a universal decline in in-person outpatient care utilization, with variations across countries. Diagnostic and screening procedures, as well as in-person visits, were more affected.

BMJ OPEN (2022)

Review Emergency Medicine

Effect of heart failure on the outcome of COVID-19-A meta analysis and systematic review

Emir Yonas et al.

Summary: This systematic review and meta-analysis found that patients with heart failure are at increased risk for hospitalization, poor outcome, and death from COVID-19. A significant difference in mortality was observed between patients with and without heart failure, with the former group having a higher mortality rate.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Heart failure and COVID-19

Feras Bader et al.

Summary: Heart failure is a common disease state that may occur in COVID-19 patients, presenting unique challenges that require careful understanding of hemodynamics and diagnostics for appropriate triage and management. Abnormal cardiac biomarkers in COVID-19 are influenced by various mechanisms, including viral entry, direct cardiac injury, increased thrombotic activity, and stress cardiomyopathy. Understanding the interaction between heart failure medications, COVID-19 treatments, and managing patients with advanced therapies is crucial for optimal care.

HEART FAILURE REVIEWS (2021)

Review Cardiac & Cardiovascular Systems

Mechanisms of COVID-19-induced heart failure: a short review

Ernest A. Adeghate et al.

Summary: The global pandemic of COVID-19 caused by SARS-CoV-2 has resulted in over 42.5 million infections and 1.15 million deaths, significantly impacting public health and the economy. In addition to severe respiratory distress syndrome, COVID-19 can also lead to heart failure through various mechanisms, requiring different approaches such as social distancing, drug therapy, and vaccine development to mitigate its impact.

HEART FAILURE REVIEWS (2021)

Editorial Material Cardiac & Cardiovascular Systems

Promoting Health Equity in Heart Failure Amid a Pandemic

Ersilia M. DeFilippis et al.

JACC-HEART FAILURE (2021)

Article Public, Environmental & Occupational Health

Racial, Economic, and Health Inequality and COVID-19 Infection in the United States

Vida Abedi et al.

Summary: This study reveals that there are racial, economic, and health disparities in the population infected by and dying from COVID-19 in the United States. Factors such as diverse demographics, education levels, income levels, poverty rates, and disabilities contribute to the risk of infection and mortality. Urban areas may have better access to care, whereas higher poverty and disability rates in some counties may result in a lower infection rate but a higher death rate due to comorbidities and limited healthcare access.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2021)

Article Cardiac & Cardiovascular Systems

COVID-19 and Cardiovascular Disease

Kevin J. Clerkin et al.

CIRCULATION (2020)

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 is, in the end, an endothelial disease

Peter Libby et al.

EUROPEAN HEART JOURNAL (2020)

Article Public, Environmental & Occupational Health

Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020

Mark É. Czeisler et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Letter Medicine, General & Internal

Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations

Sameer S. Kadri et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19

Jesus Alvarez-Garcia et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association

Emelia J. Benjamin et al.

CIRCULATION (2019)

Review Cardiac & Cardiovascular Systems

Endothelial Dysfunction, Arterial Stiffness, and Heart Failure

Catherine N. Marti et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)